Dr Reddys Laboratories (RDY) Return on Invested Capital (2009 - 2023)

Dr Reddys Laboratories (RDY) has reported Return on Invested Capital for 15 consecutive years, with 3093.24% the latest figure, recorded in Q2 2023.

• Quarterly Return on Invested Capital changed N/A year-over-year to 3093.24% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 3093.24% (changed N/A YoY) and the FY2026 annual result came in at 0.01%, down 2.0% from the prior year.
• Return on Invested Capital slipped to 3093.24% in Q2 2023 per RDY's latest filing, from 3489.37% in the prior quarter.
• Over the last five years, Return on Invested Capital for RDY reached as high as 4824.89% in Q4 2022 and fell as low as 0.0% in Q3 2020.
• A 5-year average of 1220.2% and a median of 0.0% in 2020 frame the typical range for Return on Invested Capital.
• The largest YoY upside for Return on Invested Capital was 0 bps in 2019 against a maximum downside of 0 bps in 2019.
• Year by year, Return on Invested Capital stood at 0.0% in 2019, then tumbled by 78 bps to 0.0% in 2020, then surged by 437 bps to 0.0% in 2021, then surged by 172578332 bps to 4824.89% in 2022, then tumbled by 36 bps to 3093.24% in 2023.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 3093.24%, 3489.37%, and 4824.89% for Q2 2023, Q1 2023, and Q4 2022 respectively.